Jenni Daniella, Hofbauer Günther F L
Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
Curr Probl Dermatol. 2015;46:49-57. doi: 10.1159/000366535. Epub 2014 Dec 18.
Organ transplant recipients (OTRs) have a 65- to 250-fold increased risk of the development of cutaneous squamous cell carcinoma in the wake of immunosuppression. The combination of ultraviolet light and properties of immunosuppressive drugs potentiate skin cancer formation. Due to decreased peritumoral inflammation, the thickness and invasion of epithelial skin lesions are often underestimated clinically. Rapid tumor progression and aggressive tumor behaviors occur frequently in the OTR population. Tenderness and pain in a skin lesion may indicate its potential invasion beyond the basal membrane and the need for surgical removal. All patients should receive extensive education on ultraviolet avoidance and protection. In particular, a preventive and aggressive treatment of actinic keratosis in areas of field cancerization is recommended to cut down on the high morbidity and avoid the mortality associated with actinic keratosis and invasive squamous cell carcinoma in OTRs.
器官移植受者(OTR)在免疫抑制后发生皮肤鳞状细胞癌的风险增加65至250倍。紫外线和免疫抑制药物的特性共同作用会促进皮肤癌的形成。由于肿瘤周围炎症减少,临床上上皮性皮肤病变的厚度和浸润程度常常被低估。OTR人群中肿瘤进展迅速和侵袭性肿瘤行为频繁发生。皮肤病变处的压痛可能表明其有潜在的突破基底膜的浸润,需要手术切除。所有患者都应接受关于避免和防护紫外线的广泛教育。特别是,建议对野灶性癌变区域的光化性角化病进行预防性和积极治疗,以降低高发病率,并避免与OTR中的光化性角化病和浸润性鳞状细胞癌相关的死亡率。